Metropolis Healthcare Fair Value
Metropolis Healthcare (METROPOLIS) average fair value is ₹133.54 across 9 valuation models — P/E Based Valuation, P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF), vs a current market price of ₹536.15 (-75.09%), fair value range ₹4.55–₹360.24. Examine Metropolis Healthcare quarterly earnings for recent quarterly revenue, profit and EPS trends.
Fair Value Analysis Export
METROPOLIS Fair Value vs Current Price — Valuation Summary
METROPOLIS average fair value, fair value range, price gap and valuation status across 9 models: P/E Based Valuation, P/B Based Valuation, Dividend Discount Model, Price-to-Sales Valuation, Asset-Based Valuation, Earnings Growth Model (PEG), Peter Lynch Fair Value, Benjamin Graham Number, Discounted Cash Flow (DCF). For live price and a broader fundamental view, visit METROPOLIS stock price BSE.
P/E Based Valuation
P/B Based Valuation
Dividend Discount Model
Price-to-Sales Valuation
Asset-Based Valuation
Earnings Growth Model (PEG)
Peter Lynch Fair Value
Benjamin Graham Number
Discounted Cash Flow (DCF)
METROPOLIS Fair Value Analysis — Data Sources & Coverage
Metropolis Healthcare financial data sources, valuation methods applied and sector benchmarks used — 2026 financial year. See METROPOLIS P/B ratio history to compare market price against book value per share.
Available Data Sources: Financial statements, dividend history, balance sheet data , sector comparisons.
Data Currency: Financial data is from the current year (2026).
METROPOLIS vs Healthcare Services Sector Peers — P/E, P/B & Market Cap
Metropolis Healthcare P/E ratio, P/B ratio and market capitalisation vs Healthcare Services sector peers — relative valuation comparison.
| Company | Symbol | P/E Ratio | P/B Ratio | Market Cap (₹ Cr) |
|---|---|---|---|---|
| One Global Service Provi… | ONEGLOBAL | 14.84 | 9.12 | ₹920 |
| Suraksha Diagnostic | SURAKSHA | 40.64 | 5.71 | ₹1,356 |
| Gujarat Kidney and Super… | GKSL | 83.28 | 3.9 | ₹1,117 |
| Invicta Diagnostic | INVICTA | 17.24 | 1.68 | ₹80 |
| Jupiter Life Line Hospit… | JLHL | 44.49 | 5.79 | ₹8,320 |
Important Disclaimer
This fair value analysis is for informational and educational purposes only. The calculations are based on publicly available financial data and various valuation methodologies.
This analysis does not constitute investment advice, recommendations, or suggestions to buy, sell, or hold any securities. Past performance and financial data do not guarantee future results.
Please conduct your own research and consult with qualified financial advisors before making any investment decisions. Market conditions, company fundamentals, and other factors can significantly impact actual stock performance.